Cognitive deterioration in Alzheimer’s disease is accompanied by increase of plasma neopterin
- 31 October 2007
- journal article
- Published by Elsevier BV in Journal of Psychiatric Research
- Vol. 41 (8), 694-701
- https://doi.org/10.1016/j.jpsychires.2006.02.001
Abstract
The pro-inflammatory reaction of the immune system is a feature of healthy aging and might influence the progression of Alzheimer’s disease (AD). Neopterin is a pteridine derivative, released from macrophages upon stimulation with pro-inflammatory cytokine interferon-γ. Forty-three probable AD patients were investigated at baseline and follow up (14.5 ± 0.5 months; mean ± s.e.m.). We assessed the clinical progression by the Consortium to Establish a Registry for Alzheimer’s disease (CERAD) battery and compared cognitive changes to serum concentrations of neopterin, C-reactive protein (CRP) and antibody to cytomegalovirus (CMV). The mean neopterin concentrations increased significantly from 9.8 ± 1.0 to 13.6 ± 2.1 nM (p = 0.04). In contrast, mean CRP concentrations at baseline was 0.46 ± 0.1 and non-significantly decreased to 0.28 ± 0.04 mg/dl. Of AD patients 70% were CMV IgG-seropositive at baseline and CMV-antibody concentrations correlated with levels of neopterin (Spearman r = 0.386, p = 0.016). CERAD scores did not correlate with any of immune parameters at baseline. At follow up, the increase of neopterin correlated significantly with the decrease in the total CERAD and MMSE scores, according to the clinical progression (r = −0.353, p < 0.05 and r = −0.401, p < 0.01, respectively). Subdividing the sample with respect to baseline MMSE scores, neopterin concentrations significantly increased only in the group of MMSE <20. In the multiple testing covariated for age, gender, Apolipoprotein E-ε4 allele, time difference between both measurements, neopterin remained significantly associated with cognitive decline. In summary, neopterin concentrations correlated with cognitive decline in AD patients, which might be due to high CMV seropositivity in that population.Keywords
This publication has 40 references indexed in Scilit:
- [O1‐04‐03]: Novel infectious biomarkers of cognitive impairmentAlzheimer's & Dementia, 2005
- Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly PersonsJournal of Virology, 2005
- How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytesAging Cell, 2004
- Serum markers of monocyte/macrophage activation in patients with Alzheimer's disease and other types of dementiaClinical Biochemistry, 2003
- Elevated Plasma Neopterin Levels in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2000
- TNFα plus IFNγ induce the production of Alzheimer β‐amyloid peptides and decrease the secretion of APPsThe FASEB Journal, 1999
- Summary of the II International Symposium on CytomegalovirusAntiviral Research, 1998
- Brief Screening Tests versus Clinical Staging in Senile Dementia of the Alzheimer TypeJournal of the American Geriatrics Society, 1990
- A Verbal Memory Test With High Predictive Accuracy for Dementia of the Alzheimer TypeArchives of Neurology, 1989
- The Mini-Mental State ExaminationArchives of General Psychiatry, 1983